Integer Holdings Corp.

11/07/2024 | Press release | Distributed by Public on 11/07/2024 07:46

Integer to Showcase Life-Enhancing Innovations and Technologies, Recent Irish Expansion During COMPAMED 2024, November 11 – 14

Integer to Showcase Life-Enhancing Innovations and Technologies, Recent Irish Expansion During COMPAMED 2024, November 11 - 14

PLANO, TEXAS - Nov. 7, 2024 - Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will exhibit at COMPAMED from Nov. 11 - 14, 2024, in Düsseldorf, Germany, at the Messe Düsseldorf in Hall 8B / Booth N29.

Attendees are invited to learn more about Integer's expanded presence and investment in Ireland, including a new Catheter Centre of Excellence in Galway, Ireland, and expansion of its New Ross, Ireland, site, as well as how the company accelerates customers' time to market by integrating R&D, prototyping and manufacturing.

During COMPAMED, Integer will also highlight its advanced solutions for complex delivery systems, implantable textiles, electrophysiology catheters, steerable guiding sheaths, and structural heart delivery systems, which cater to the growing demand for minimally invasive procedures, where precision and performance are critical.

Integer will additionally showcase a recently added capability - micro-machined components with Hierarchical Surface Restructuring (HSR™). This advanced surface treatment technology is used to modify the surface of implantable electrodes and microelectrode arrays using ultrashort pulse lasers. The process is tunable, providing a truly engineered surface morphology.

"As a trusted partner to OEMs and start-ups, Integer is committed to developing and manufacturing the next-generation of cardiovascular devices to improve patient outcomes," said Payman Khales, President, Cardio & Vascular. "Our ability to deliver unparalleled expertise, value, collaboration and life-enhancing innovation directly supports our customers' growth strategies in bringing new therapies to market faster. We look forward to discussing this and more at COMPAMED."

Learn more about Integer at www.integer.net.

About Integer ®
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, Integer is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.